Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by cher0424 – China, 2015-01-08 07:28 (3393 d 03:18 ago) – Posting: # 14243
Views: 28,129

Dear Detlew

❝ Since according to 1. a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis it can't be included in the statistical analysis (of whatever) since no PK metrics are available.


Thank you for your response.
One more query, why a subject with two periods, each with reference, will not be included in the pharmacokinetic analysis for SWR?

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,664 registered users;
68 visitors (0 registered, 68 guests [including 4 identified bots]).
Forum time: 11:47 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5